In an exciting development for the tech community, Northflank, a leading self-service developer platform, has successfully raised $22 million in its latest funding round. This innovative company, which specializes in automating and unifying the deployment of workloads across various cloud environments, is poised to revolutionize how developers manage their applications at scale. With this new capital infusion, Northflank plans to enhance its platform capabilities, ensuring users experience even greater efficiency and simplicity in deploying their workloads, regardless of the cloud service they choose. The funding will also allow Northflank to invest in their core technology, further streamlining deployment processes and promoting seamless integration across environments. As businesses increasingly migrate to multi-cloud strategies, Northflank is committed to providing the tools necessary for developers to maximize performance and minimize complexity, all at a scale custom-fitted to their needs. This funding round speaks volumes about investor confidence in Northflank's vision and the demand for its comprehensive solutions that meet the evolving challenges of modern cloud computing. Going forward, Northflank is eager to leverage this funding to expand its team and enhance support, ensuring that developers everywhere can deploy workloads with unprecedented ease and efficiency. The company’s mission to empower developers is now backed by significant financial support, setting the stage for an exciting future filled with innovation and growth.

Northflank Secures $22 Million in Series A Funding to Revolutionize Developer Platforms
Get the full Northflank company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
$2.5M Unknown
today

Edify Systems
When you're running 10+ stores, the cracks in your operations become expensive. Inconsistent stock levels across sites, manual processes that don't scale, food waste that eats into margins, and zero real time visibility for the ops team. That's what Edify solves. Our AI powered platform gives operations leaders a single system to manage inventory, plan production, and report across their entire estate, whether that's 20 locations or 500. Built in intelligence surfaces the insights that matter, so your team spends less time in spreadsheets and more time running operations. What we cover: Inventory management across all sites. AI driven production planning and prep workflows. Operational reporting and real time visibility. Multi location scalability built in from day one. We work with QSR brands and multi site coffee chains who have outgrown spreadsheets and fragmented systems but need something purpose built for high volume, multi unit operations. If your back of house is holding back your growth, we should talk.
$4.0M Seed
today

Generalist
Generalist is an AI robotics company building general intelligence for the physical world. The founding team includes engineers from OpenAI, Google DeepMind, and Boston Dynamics. The company embraces both large-scale AI and robotics as core to its DNA.
$400.0M Unknown
today

Scotch
From neighborhood stores to destination warehouses, liquor retailers of all sizes have been held back by manual tasks, slow systems and limited business intelligence. So we decided to build something better — smarter software that saves time and improves margins so independent retailers could focus on their customers, not manually managing inventory.
$20.0M Series a
today

Kempfer / K Creative Office
Based in São Paulo, we specialize in social media creation and content, delivering creative solutions that connect, engage, and inspire Com sede em São Paulo, somos especialistas em criação e conteúdo para social media, entregando soluções criativas que conectam, envolvem e inspiram.
$1.3M Unknown
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Scotch United States | Series a | $20.0M | today |
| 2 | ![]() vorteX-io France | Series a | $9.2M | today |
| 3 | ![]() Scispot Canada | Series a | $8.0M | today |
| 4 | ![]() Lassie United States | Series a | $47.0M | today |
| 5 | ![]() Terra AI United States | Series a | $20.0M | 1d ago |



